CN1994352B - Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction - Google Patents

Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction Download PDF

Info

Publication number
CN1994352B
CN1994352B CN2007100076867A CN200710007686A CN1994352B CN 1994352 B CN1994352 B CN 1994352B CN 2007100076867 A CN2007100076867 A CN 2007100076867A CN 200710007686 A CN200710007686 A CN 200710007686A CN 1994352 B CN1994352 B CN 1994352B
Authority
CN
China
Prior art keywords
fructus xanthii
total glucosides
glucosides extract
composition
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007100076867A
Other languages
Chinese (zh)
Other versions
CN1994352A (en
Inventor
秦路平
韩婷
张巧艳
黄宝康
郑汉臣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CN2007100076867A priority Critical patent/CN1994352B/en
Publication of CN1994352A publication Critical patent/CN1994352A/en
Application granted granted Critical
Publication of CN1994352B publication Critical patent/CN1994352B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to an application of xanthostrumarin extractive, wherein said xanthostrumarin extractive comprises diterpene compound, phenolic acid compound and other extractives while their contents are 0.5%-99%, 0.5%-99%, and 0.5%. And the production uses general extraction, separation and purification. The extraction is solvent extraction method; the separation and purification uses solvent extraction method and porous adsorption resin method. The inventive extractive can treat coryza, nasal sinusitis, etc. It has simple production and stable property.

Description

Fructus Xanthii total glucosides extract is used to prepare the purposes of anti-inflammatory response product
The application is dividing an application of application for a patent for invention " Fructus Xanthii total glucosides extract being used to prepare the purposes of anti-inflammatory response product ", the applying date of original application is on 03 28th, 2005, application number is 200510024693.9, and invention and created name is: Fructus Xanthii total glucosides extract is used to prepare the purposes of anti-inflammatory response product.
Technical field
The present invention relates to medicine, food, technical field of beverage, specifically relate to the purposes of Chinese medical extract, more particularly relate to the purposes that the Chinese medicine Fructus Xanthii total glucosides extract is used to prepare the anti-inflammatory response product.
Background technology
(1) research overview of Siberian Cocklour Fruit
1, plant resources and application scenario
Siberian Cocklour Fruit (Fructus Xanthii), fruit for the drying and ripening band involucre of feverfew Siberian cocklebur (Xanthium sibirium Patr.), have another name called that wild eggplant, sheep band is returned, Indian Skullcap Herb, thorn class, sticking certain herbaceous plants with big flowers, grey son etc., be the Chinese Pharmacopoeia kind, China all produces in most of area, and resource is extremely abundant.The traditional Chinese medical science thinks that its flavor is arduous, warm in nature, returns lung, liver two warps, has the effect of sweating, diffusing rheumatism, relieving stuffy nose, pain relieving.Tradition is used for the treatment of headche due to wind-cold, the nasosinusitis runny nose, and the rubella itch, arthritis with fixed pain caused by dampness contraction etc. (the Pharmacopoeia of People's Republic of China council. Pharmacopoeia of People's Republic of China [S]. one one. Beijing: Chemical Industry Press, 2000:128); Modern clinical treat with it tetter such as acute and chronic rhinitis, sinusitis paranasal sinusitis, trachitis, pain in the waist and lower extremities and rubella, scabies leprosy (State Administration of Traditional Chinese Medicine. China's book on Chinese herbal medicine [M]. the 7th. Shanghai: Shanghai science tech publishing house, 1999:1013-1016).
2, chemical ingredients
Studies show that the contained chemical ingredients of cocklebur mainly is sesquiterpene lactones, volatile oil and water-soluble glycoside, division is as follows:
(1) mainly contains the guainane type in the sesquiterpene lactones compound cocklebur and split guainane type lactone compound, mainly contain xanthinin (xanthinin, promptly latent Siberian cocklebur lactone), xanthumin (xanthumin, it is the Siberian cocklebur lactone, steric isomer for xanthinin), Siberian cocklebur booth (xanthatin, i.e. xanthinin) and their derivative etc.Also have xanthanol (xanthanol), xanthinosin in addition, and the xantholide A among the X.canadense, xantholide B, pungiolide A among ziniolide among the X.catharticum, lasidiol p-methoxybenzoate and the X.pungens, multiple compound (Salinas-A such as pungiolide B, De-Ruiz-RE, Ruiz-SO.Sterols, flavonoids and sesquiterpenic lactonesfrom Xanthiun spinosum (Asteraceae) .Acta Farm Bonaerense, 1998,17: 297; And Kis-I, Racz-GGlycoside contents of sitosterol from leaves of Xanthiun spinosum and X.italicum.FarmaciaBucharest, 1988,36 (1): 55; And Ahmed-AA.New vomifoliol derivative from Xanthiun pungens.Pharmazie, 1990,45: 698).
(2) volatile oil Ahijja-MM etc. extracts volatile oil (Ahijja-MM in the Siberian cocklebur X..strumarium leaf with steam distillation, Nigam-SS.Chemical examination of the essential oil from the leaves of Xanthiunstrumarium (Linn.) .Flavour Ind, 1970,1: 627), discovery contains d-limonene (d-limonene, 35%), isopropyltoluene (p-cymene, 5%), β-cloves alkene (beta-caryophyllene, 6%), terpinolene (terpinolene, 7.3%), 1-α-Zi Luolantong (1-alpha-ionone, 10.9%), the high terpene alcohol of d-(d-carveo1,25%) and α-Pai Xi (alpha-pinene, 0.4%).Taher-HA etc. have analyzed the volatile oil component (Taher-HA among the X.cavanillesii, Ubiergo-GO, Talenti-ECJ.Constituents of the essential oil of Xanthiun cavanillesii.J Nat Prod, 1985,48:857.), wherein contain monoterpene hydrocarbon 55.2%, the monoterpenoid 14.2% of oxidation, sesquiterpene hydro carbons 11.3%.Guo Yahong etc. from the volatile oil of Siberian Cocklour Fruit, analyze 17 chemical ingredientss and calculated its relative percentage composition (Pan Jiongguang is etc. the research of volatile oil in the Siberian Cocklour Fruit for Guo Yahong, Li Jiashi. CHINA JOURNAL OF CHINESE MATERIA MEDICA, 1994,19 (4): 235).
(3) water-soluble glycoside Song Zhen jade etc. has been isolated a kind of material (AA2 by name temporarily) with glycoside character from the water logging agent of Siberian Cocklour Fruit as far back as the sixties in last century, may be the main toxic component (Song Zhenyu of Siberian Cocklour Fruit, Zhang Lingyun, thank to wisdom, Deng. toxic ingredient of Siberian Cocklour Fruit and pharmacological action thereof. Acta Pharmaceutica Sinica, 1962,9 (11): 678).MacLeod-JK etc. extract from the bur of noogoora burr X.pungens and have obtained two kinds of water-soluble deleterious kaurene glucosides (kaureneglycoside) constituents (MacLeod-JK, Moeller-PD, Franke-FP.Two toxic glycosides from the burrs ofXanthiun pungens.J Nat Prod, 1990,53: 451), identify through two dimensional NMR and mass-spectrometric technique, determine that its structure is the derivative of carboxyl atractyloside (carboxyatractyloside).In addition, also from Siberian Cocklour Fruit and Herba Xanthii mongolici, extract with a kind of water-soluble malicious glycosides, through be accredited as atractyloside (atracyloside) (Sun Zeren is etc. the toxic ingredient in the Herba Xanthii mongolici kind benevolence for Wang Suxian, Ren Lijuan. herbal medicine, 1983,14 (12): 1).
(4) also contain xanthostrumarin (strumaroside, i.e. β-Gu Zaichun glucoside), 8-(Δ 3-isopentene group)-5,7,3 ' in other Siberian cockleburs, 4 '-kaempferol, and coffic acid and 1, the 4-dicaffeoylquinic acid.In addition, still contain alkaloid, tannin, chalcone derivative, triterpene compound, glucose, fructose, amino acid, tartrate etc.
3, pharmacologically active
(1) anti-microbial effect Siberian Cocklour Fruit decoction has stronger restraining effect external to multiple microorganisms such as streptococcus aureus, anthrax bacillus, streptococcus pneumoniae, beta streptococcus and diphtheria corynebacteriums.Siberian Cocklour Fruit acetone or alcohol extract is to trichophyton purpureatum, and its aqueous extract has antifungic action to trichophyton.Open and just equaling to studies confirm that in 1988 the Siberian Cocklour Fruit decoction is 25%～50% at external direct inhibiting rate to the hepatitis B virus DNA saccharan, show that it has the hepatitis virus resisting effect (just opening, permitted eastwards, Du Shaocai, experimental study Deng .60 kind herbal medicine hepatitis B virus resisting. journal of Beijing Medical University, 1988,20 (3): 211).
(2) the effect Siberian Cocklour Fruit decoction to cardiovascular systems has restraining effect to isolated frog heart and guinea pig heart, makes decreased heart rate, and heart convergent force weakens, and can expand rabbit ear blood vessel, frog blood vessel is then expanded post shrinkage earlier, and the Siberian Cocklour Fruit injection liquid can make rabbit and the of short duration decline of dog blood pressure.Glycoside composition AA2 has slight hypotensive activity to rat, and can strengthen vascular permeability (Song Zhenyu, Zhang Lingyun thank to wisdom, etc. toxic ingredient of Siberian Cocklour Fruit and pharmacological action thereof. Acta Pharmaceutica Sinica, 1962,9 (11): 678).
(3) to the effect Fructus Xanthii extract (being equivalent to crude drug 0.2g/ml) of blood system can significant prolongation thrombin of beef cohesion human fibrinogen time, obvious antithrombin effect is arranged.The Siberian Cocklour Fruit methanol extract can recover the reduction because of rabbit cholesterol due to the fasting and triglyceride level rapidly, also can make phospholipids content that to a certain degree rise is arranged.
(4) the Immune Effects Siberian Cocklour Fruit all there is obvious restraining effect to cellular immunization and the humoral immune function of the purebred mouse of C57/BL.Siberian Cocklour Fruit makes auxiliary type T cell, and (be called for short: TH) (be called for short: TS) cell count reduces, and TH/TS ratio is reduced with inhibition type T cell.Siberian Cocklour Fruit all has remarkable reduction effect to the beta-endorphin in hypothalamus and the blood plasma.In addition, Siberian Cocklour Fruit still can reduce interleukin II and (be called for short: IL-2) active and IL-2 content receptor, can obviously reduce the release of histamine in the cell, this can be used for one of mechanism for the treatment of anaphylactic disease (Wang Longmei for Siberian Cocklour Fruit, Fu Huidi, Zhou Zhilan. wolfberry fruit, the bighead atractylodes rhizome, the root of Chinese wild ginger, Siberian Cocklour Fruit are to the influence of interleukin II expression of receptor. Chinese clinical pharmacy magazine, 2000,9 (3): 172).
(5) the antioxygenation Fan Jing slope antioxygenation of studying Siberian Cocklour Fruit in 1994, show Siberian Cocklour Fruit decoction 0.5g crude drug/only irritate stomach, every day 1 time, continuous 10d, can reduce lipid peroxidation effectively, reduce and organize lipid peroxide (to be called for short: LPO) content, (be called for short: SOD) activity has raising trend to superoxide-dismutase, show the removing ability of Siberian Cocklour Fruit energy enhancing body to free radical, the infringement of minimizing radical pair body (Fan Jingpo. Siberian Cocklour Fruit, the root of Chinese wild ginger, wolfberry fruit, the bighead atractylodes rhizome is to the influence of mouse tissue Radical Metabolism. Chinese materia medica information, 1994, (2): 48).
(6) anti-inflammatory and analgesic activity Liu Qing increase etc. 1988 pharmacologically actives of having set forth Fructus Xanthii extract (Liu Qingzeng, Wang Jinlan. Japan is to some progress of Chinese medicine pharmacological research in recent years. Pharmacology and Clinics of Chinese Materia Medica, 1988,4 (2): 50).Siberian Cocklour Fruit methanol extract 250mg/kg abdominal injection is to the swollen inhibiting rate 30%～60% of rat carrageenan foot; The 1000mg/kg subcutaneous injection, the inhibiting rate that the mouse acetic acid twisting is reacted is 10%～30%, shows that this product has certain anti-inflammatory and analgesic activity.Add flavor Siberian Cocklour Fruit ball and have good antiinflammation, comprising: can significantly reduce acetic acid induced mice abdominal cavity azovan blue seepage discharge, can significantly reduce the swelling degree of dimethylbenzene induced mice otitis disease.Still have good analgesic activity, but significant prolongation acetic acid induced mice writhing response time of occurrence (Ma Ping, Li Hong. the progress of Siberian Cocklour Fruit. herbal medicine, 1999,30 (8): 634).
(7) other there are some researches show that also the Siberian Cocklour Fruit aqueous extract reaches 50%～70% at external inhibiting rate to cervical cancer cell; Fructus Xanthii extract (is called for short: HMG-Co-A), calcium channel blocker acceptor and cholecystokinin etc. have restraining effect in various degree angiotensin receptor, beta-hydroxy-Beta-methyl pentanedioic acid coenzyme A.
4, the clinical application of folk prescription and compound (Li Hong, week scheme, the pharmacological action of Siberian Cocklour Fruit and compound preparation and clinical progress. Mountain Western Medicine S University's journal, 2004,35 (3): 313-314)
(1) treatment rhinopathy
Treatment rhinitis chronic rhinitis is a kind of common disease, frequently-occurring disease.Someone is the plus-minus sanction on the basis of former Cang'erzi San, and at random 96 routine patients are divided into treatment group and control group, 1 month is 1 course of treatment, clinical observation, there was no significant difference between two groups, add flavor Siberian Cocklour Fruit pill for curing chronic rhinitis and ' Biyanwan ' for treating rhinitis near and be better than ' Biyanwan ' for treating rhinitis slightly.
The treatment sinusitis paranasal sinusitis is closed Cang'erzi San treatment chronic sinusitis with Radix Scutellariae Decoction, clinical observation 108 examples, and total effective rate 94.4%, can obviously take effect a course of treatment after the general medication.It is remarkable to share treatment chronic sinusitis in children effect with Siberian Cocklour Fruit mixture and Vagran.Siberian Cocklour Fruit bakes into brown back levigation or powder system honeyed bolus, treatment of allergic rhinitis, and most of patients transference cure or improvement, or outbreak reduces.Also useful ancient prescription Cang'erzi San adds treatment chronic sinusitis 67 examples such as myrobalan, earthworm, 42 examples of fully recovering, 20 examples that take a turn for the better, invalid 5 examples, total effective rate 92.54%.
The treatment nasosinusitis traditional Chinese medical science is classified as nasosinusitis with acute purulent nasosinusitis.With Siberian Cocklour Fruit mixture treatment acute purulent nasosinusitis 200 examples, treatment is organized 100 examples and is taken the Siberian Cocklour Fruit mixture, and control group 100 examples are selected symptomatic treatments such as penicillin, trimethoprim-sulfamethoxazole for use.Clinical treatment is the result show, treatment group and control group total effective rate are respectively 99% and 95% (P＞0.05), no significant difference.Grey, hot decoction also commonly used is clinically treated nasosinusitis and allergic rhinitis, and the report of also useful jade screen Cang'erzi San treatment of allergic rhinitis etc. have all illustrated the contribution of Siberian Cocklour Fruit in the treatment rhinopathy.
(2) treatment cancer Siberian Cocklour Fruit becomes compound preparation with different prescription forms, effectively cures many cases nasopharyngeal carcinoma, CARCINOMA OF THE NASAL CAVITY clinically; Treatment penile cancer 3 examples, and cooperate the operation clinical cure; And treat intracranial tumors, neural system malignant tumour, brain tumor etc. and all play certain curative effect.
(3) treatment odontopathy bibliographical information is treated intractable toothache 98 examples, satisfactory effect with folk prescription handed down from one's ancestors.Also useful Siberian Cocklour Fruit, each 15g of radix scrophulariae add and are decocted in water for oral dose, the treatment medicable report of having a toothache.
(4) treatment dermatitis 25 examples (accounting for 65.8%) of in 38 routine dermatitis patients, fully recovering, produce effects 10 examples (accounting for 26.8%), invalid 3 examples (accounting for 7.9%), total effective rate 92.1%.
(5) out-patient of treatment upper respiratory tract infection bibliographical information 30 routine upper respiratory tract infection uses to add the flavor Siberian cocklebur in treating, 26 examples of fully recovering (accounting for 86.7%), 3 examples that take a turn for the better (accounting for 10.0%), invalid 1 example; Total effective rate reaches 96.7%.Take medicine minimum 2 doses, maximum 5 doses.
(6) treatment diarrhoea Siberian cocklebur is in about 50g～70g, after adding the 3000ml clear water and soaking 30min, uses 15min at a simmer again after being fried boiling with high heat, leaches soup, and is cool to 35 ℃～38 ℃, with warm liquid dipping bath or immersion shank and sufficient every day 3 times; Cure 46 examples, curative ratio is 95.77%, effective 1 example, and efficient is 2.15%, invalid 1 example (accounting for 2.15%).
(7) the treatment otitis media has bibliographical information to adopt Siberian cocklebur to cooperate antibiotic xeraphium treatment simple form suppurative otitis media to receive good therapeutic action in loosing clinically.
(8) treatment typhoid fever Siberian cocklebur was soaked heated and boiled 1h in 6000g with clear water, leached decocting liquid, fry in shallow oil 3 times with connecting with quadrat method, 3 decocting liquids are mixed, filter, slow fire is concentrated into 2000ml, add Tegosept E 10g, shake up, effectively treat typhoid fever 15 examples, the fastest 10h of fever time, 7 routine blood, excrement, bile Corynebacterium diphtheriae positive person all turn out cloudy after the treatment.
(9) the bright Siberian cocklebur of treatment dysentery is cleaned and mashes in 100g, adds decocting 15min, removes slag, and squeezes into 2～3 in egg, in soup, boil, before outbreak with soup and egg with clothes, do not heal for 1 time, the method that can connect is obeyed again, it is good to treat the dysentery curative effect.
(10) treatment sore furuncle Siberian cocklebur is in, Great Burdock Achene, Radix Et Rhizoma Rhei etc., and 1 dose of every day, decocting divides clothes 2 times; Example surplus the 4-8 agent continuously, treatment sore furuncle 30 all obtains good effect.
(11) other clinical applications utilize in addition clinically Siberian cocklebur in and the report of compound preparation treatment pain in the waist and lower extremities, parotitis, the ulcer of lower limb, all received certain curative effect.
Siberian Cocklour Fruit is singly used clinically or forms compound with other Chinese medicines, be used for the treatment of the common and difficult and complicated illness of nose section such as acute and chronic rhinitis, sinusitis paranasal sinusitis and allergic rhinitis, all obtained curative effect preferably, as " grey hot nasal drop ", " Cang'erzi San ", " Siberian cocklebur Radix Angelicae Sinensis drink ", " grey hot fish root of Dahurian angelica soup " etc., all be hot and suffocating clearly, dampness elimination is turbid, open the famous prescription of nose key, used for many years clinically, curative effect is better.But because to its chemical constitution study not deeply, the pharmacological screening deficiency causes reactive site and activeconstituents indeterminate and do not have feasible quality standard, has limited the further development and utilization of Siberian Cocklour Fruit.
(2) progress of sinusitis paranasal sinusitis
Sinusitis paranasal sinusitis (sinusitis) is because bacterium is invaded nasal sinus, destroys sinus tissue, the acute or chronic inflammatory diseases that causes nasal sinus to take place.Site of pathological change is the highest with the sickness rate of maxillary sinusitis, secondly is ethmoiditis, metopantritis and sphenoiditis, and getting involved as all nasal sinus then is called pansinusitis (pansinusitis).
Acute and chronic sinusitis paranasal sinusitis is a kind of common disease and frequently-occurring disease, and according to the literature, only just there are 3,700 ten thousand chronic sinusitis patients in the U.S.; Some American Studies personnel think that global sinusitis paranasal sinusitis patient accounts for 14% (about 800,014,000 populations) of world's total population, and the case load of sinusitis paranasal sinusitis is year by year all in quick increase.In China, because the region difference, various places sinusitis paranasal sinusitis sickness rate fluctuates between 10.7%～44.5%.According to the clinical data statistics, chronic sinusitis morbidity number accounts for Otorhinolaryngologic Department first visit patient's 13.02%.Especially in southern area of China, owing to have a humid climate, the sinusitis paranasal sinusitis sickness rate is very high, having approximately more than 1/3 among the first visit patient of Shanghai Changhai Hospital Otorhinolaryngologic Department outpatient service is all kinds of sinusitis paranasal sinusitis patients, wherein patient age accounted for 76.0% below 30 years old, there be 6.4%, 50 years old between 40～50 years old and still have 1% or 2% later on.
Since the hole stenostomy, factors such as unfavorable drainage and allergic constitution, this sick Chang Fanfu outbreak, delay is difficult.And should the disease course of disease long, often again with symptoms such as headache, dizziness, hypomnesis, thereby bring utmost point disadvantageous effect for patient's study, work, life.
In addition, after sinusitis paranasal sinusitis took place, inflammation can be expanded the infringement adjacent tissue, very easily causes osteomyelitis, eye socket phlegmon, piitis, cerebral abscess, and serious purulent sinusitis even also can cause septicemia directly jeopardizes patient's life.Repetitious stimulation that there are some researches prove chronic sinusitis also can cause canceration.
Modern study shows that chronic sinusitis is by the coefficient result of multiple factor, and still wherein many factors still fail to be understood by people, and its pathogenesis is not illustrated as yet fully.In external scholar the research of its pathogenic factors is mainly concentrated on the following aspects: 1. bacterium or virus infection; 2. hole mouth nasal meatus complex body (is called for short: OMC) block; 3. mucomembranous cilium dysfunction; 4. immunologic function disorder etc.
The pathogenic bacterium of sinusitis paranasal sinusitis morbidity mostly are pyococcus, as pneumococcus, haemolysis type suis, staphylococcus etc., are bacillus secondly, as hemophilus influenza, Bacillus proteus etc.The generation of sinusitis paranasal sinusitis is most because due to two kinds of germ polyinfections clinically.The intrusion of bacterium makes host resistance impaired, and the nasal mucosa fibre function reduces, even makes the defense mechanism paralysis of mucous membrane.
Hole mouth nasal meatus complex body that studies show that in recent years, a variety of causes are caused block cause ventilation and drainage obstacle be cause the sinusitis paranasal sinusitis protracted course of disease and the main diseases of showing effect repeatedly because of.Simultaneously, above-mentioned each link is not isolated the existence, but influences each other, interacts, and has caused persistence inflammatory reaction of nasal sinus mucous membrane and irreversible pathological change.
The sickness rate height of sinusitis paranasal sinusitis, inflammation easily expansion cause severe complications, and easily outbreak repeatedly, and delay is difficult.Western medicine at present commonly used clinically mainly is microbiotic, go congested agent, the agent of reducing phlegm, pain killer, steroid and nasal spray etc., be only applicable to light disease and early stage patient and preoperative patient, and majority can only improve symptom in various degree, and sinusitis paranasal sinusitis thoroughly can't be effected a radical cure.Side effect in various degree can appear in about 2/3 sinusitis paranasal sinusitis patient in external application or after taking these Western medicine, as modal be the racephedrine nasal drop, prolonged and repeated use can cause nasal cavity vasomotion dysfunction, and the sex change slightly of olifactory nerve end forms medicamentous rhinitis at last; The microbiotic abuse then makes pathogenic bacterium produce resistance easily, also may destroy the balance of normal microflora, makes it imbalance, causes adverse consequences.In sum, though the medicine of treatment sinusitis paranasal sinusitis is many on the market, curative effect instability, in various degree drawbacks limit such as side effect have been arranged its application clinically.
(3) progress of inflammation
Exogenous damage factor and endogenous damage factor all can cause the various damaging pathologies of cell, meanwhile complex series of reactions then takes place in the part of body and whole body, with limitation with eliminate these damage factors, removing and absorption necrotic tissue, cell, and repair and damage, the defensive reaction of Here it is body, i.e. inflammation (inflammation).
The local Clinical symptoms of inflammation is red, swollen, pain and dysfunction, and the caused systemic reaction of inflammation comprises that heating and tip blood leukocytes are counted and increases.Inflammation is the first line of defence that health is resisted virus infection originally, is the protection to health.But serious or when developing into chronic inflammatory diseases when degree of inflammation, it just might cause heart attack, colorectal carcinoma and a series of other diseases of senile dementia disease etc. morning.
Clinical anti-inflammation analgesia medicine commonly used is mainly non-steroidal anti-inflammatory drugs (abbreviation: NSAIDs) at present.NSAIDs has been widely used in similar rheumatism patient and non-rheumatism patient's analgesia, comprises abdominal pain and cramps such as acute postoperative pain, chronic pain, biliary colic and renal colic.Traditional nonsteroidal anti-inflammatory drug the infringement of gi tract, coagulation function and renal function aspect occurs inevitably because of the increase of dosage, the course of treatment and patient age, has restricted its range of application.
NSAIDs mechanism of action: be the activity that suppresses cyclooxygenase (cyclooxyRenase) COX, thereby reduced the synthetic of prostaglandin(PG) PGs, reach the effect of anti-inflammatory analgesic.The COX enzyme has two kinds of isozyme, the COX-1 of basal expression, and major function is to keep the normal physiological function of stomach and intestine, kidney and other organs; The COX-2 of abduction delivering can find in brain and inflammation part and play a role.The anti-inflammatory action mechanism of NSAIDs thinks to have suppressed COX-2, and untoward reaction is because suppressed COX-1.
Non-specific NSAIDs class medicine commonly used such as Ibuprofen BP/EP (ibuprofen), Naproxen Base (naproxen), Diclofenac Sodium etc. are long and narrow because of structure, there is not selectivity, can combine with the reactive site of COX-1 and COX-2 simultaneously, both can suppress COX-1, can suppress the activity of COX-2 again.Thereby existing anti-inflammatory analgesic action, with untoward reactions such as gi tract, coagulation function and renal function are arranged often.
The subject matter of NSAIDs treatment is untoward reaction.Along with increasing progressively of age, untoward reaction is remarkable more, comprises gi tract, kidney, cardiovascular systems, central nervous system.
(4) progress of virus disease and treatment thereof
According to statistics, 60%～65% epidemic infectious diseases is caused by virus infection.The 7th part of virus type journal that propose in world's virusology conference that Paris, FRA is held in August, 2002 accused and pointed out to make human disease's virus that 29 sections are arranged, 7 subfamilies, and virus is planted in 53 residences more 1200.Sickness rate height, the virus disease that hazardness is big have 6 kinds, as the acute, chronic hepatitis due to the hepatitis virus; 8 kinds of cytomegalovirus (abbreviations: CMV) retinitis, interstitial pneumonia, herpes simplex encephalitis, eye keratitis, genital herpes, zoster, herpes labialis that the herpes virus hominis causes; Bronchitis, pneumonia, measles, parotitis, poliomyelitis that respiratory virus infection causes; Acute gastroenteritis and infantile diarrhea etc. and human immunodeficiency virus due to the enterovirus (be called for short: the acquired immune deficiency syndrome (AIDS) HIV) (be called for short: AIDS) or the like.
Though from being familiar with viral first day, human just the searching constantly resisted viral effective weapon, the treatment of virus disease, the present strong medicine of specificity that still lacks.Chang Yong medicine has following a few class clinically: the antiviral drug that 1. suppresses virus replication; 2. the immunity regulatin remedy medicine of enhancing body immunologic function; 3. at the cough-relieving of clinical symptom, ease pain, bring down a fever and curative such as anti-inflammatory; 4. prevent the anti-infective of secondary infection; 5. the vaccine of prophylaxis of viral infections; 6. the Herb of Common violet propagated of blocking virus etc.
(5) analgesic progress
Pain is human total and the very big a kind of impression of individual difference is the warning signal that health and internal organ suffer damage.Because pain is normal and autonomic nerve activity, psychology and emotional reactions weave in, and great variability is arranged, and therefore feels more difficult research than other.People are to pain for a long time, the cause of disease, the pathological knowledge that comprise migraine, rheumatic arthritis, osteoarthritis, backache, cancer pain and neuropathic pain are still very shallow, therefore, especially the treatment of neuropathic pain is still very difficult for the pain that most of disease is caused.Though the effort through more than 30 years does not all obtain satisfied the solution, its basic reason is that the nosetiology of pain and pharmacological understanding are made slow progress.At present the most frequently used anodyne be the non-steroidal anti-inflammatory medicine (be called for short: NSAIDs) and opiates, conventional NSAID s has 18 kinds, among studying nearly more than 100 kinds.Though their clinical efficacy is better, untoward reaction is bound to arouse fear, as gastrointestinal reaction, stomach ulcer, gastrorrhagia and the transformation reactions etc. of NSAIDs.Opiates then limits the use of because of its habituation in accordance with the law.Particularly to nociceptive pain (nociceptive pain), complicacy local pain syndrome (complex regional pain syndrome, be called for short: CRPS) and wound, inflammation or other diseases etc. cause that the neuropathic pain treatment difficulty due to nerve injury or the pathology is bigger, potent opioid analgesics also is difficult to prove effective.The good news is, recent years, nosetiology and the pharmacological understanding to chronic pain had breakthrough, make pathology, physiology and the therapeutic notion of chronic pain that fundamental shifts take place, break away from the out-moded convention of traditional NSAIDs and opioid drug, developed a collection of novel analgesic agent.But major part is in development or the clinical trial.In addition, external scholar is a target with N type voltage-sensitive calcium channel, trk C, E.C. 2.7.1.20, P material acceptor and cannabinol acceptor in recent years, also doing a lot of work aspect the medicine of exploitation neuropathic pain, seeking treatment neuropathic pain analgesic agent has become advanced subject clinical and basis and medicine research.
(6) pharmacology activity research of phenolic acid compound progress
1, platelet aggregation-against and prevent that seven water soluble components that thrombosis gives the quiet notes red sage root of rat from showing that salvianolic acid A and salvianolic acid B have stronger restraining effect to collagen-induced platelet aggregation, its IC to the result of study of rat platelet aggregation 50Be respectively 0.32mmol/L and 0.26mmol/L, the ADP inductive is assembled, then salvianolic acid A effectively and salvianolic acid B is invalid.Rosmarinic acid has the gentle thrombotic effect that prevents, it is one of effective constituent of red sage root anti thrombotic action.Rosmarinic acid is 50mg/kg (iv), and 100mg/kg is 41% and 55.8% (P＜0.05) to the thrombotic inhibiting rate of rat vein.
2, the microcirculation improvement obstacle is by observing mouse mesentery arteriole external caliber, blood flow rate and the change situation of flow under different condition, show salvianolic acid A and salvianolic acid B topical to the effect of having clear improvement of suprarenin induced mice mesentery microcirculation disturbance, quiet notes salvianolic acid A also has same purpose.
3, (be called for short: MDA) restraining effect of Sheng Chenging is all strong than vitamin-E to the mouse liver even slurry mda for anti peroxidation of lipid salvianolic acid A, salvianolic acid B, salvianolic acid C and rosmarinic acid, its inhibition strength is followed successively by salvianolic acid A＞salvianolic acid C＞salvianolic acid B＞rosmarinic acid, and four kinds of compositions are stronger 10～100 times than N.F,USP MANNITOL to the scavenging(action) of hydroxy radical qiao.The mouse that oral 50% ethanol 15ml/kg is caused acute alcoholism, (100mg/kg * 3, po) after the treatment, mouse liver MDA content significantly reduces with rosmarinic acid.Salvianolic acid A, salvianolic acid B and rosmarinic acid are to (being called for short: NADPH) or by Fe by vitamins C-Triphosphopyridine nucleotide, reduced 2+The rat brain that one halfcystine brings out, liver, the MC lipid peroxidation of kidney all have very strong restraining effect, and its effect power is followed successively by salvianolic acid A, salvianolic acid B, rosmarinic acid, and be stronger 100～1000 times than the support one's family effect of case E of antioxidant.Salvianolic acid A can suppress Fe 2+The forfeiture of the rat heart that one halfcystine causes and the mitochondrial lipid peroxidation of liver and atpase activity suppresses mitochondrial swelling and the decline of liver mitochondrion membrane fluidity that lipid peroxidation causes.
4, the cardiac toxic to the prophylactic effect Zorubicin of Zorubicin cardiac toxic is because of it produces free radical at heart, due to the injury of myocardium plastosome.Salvianolic acid A can be removed the OH that is produced by Zorubicin, and the cardiac toxic that Ah mould's index is risen has prophylactic effect, and the Zorubicin antitumor action is not had influence.
5, the anti-gastric-ulcer salvianolic acid A has the pig of inhibition stomach H +-K +The effect of/ATP enzyme and PNPP enzyme, IC 50Be respectively 5.2 * 10 -7With 1.7 * 10 -6Mol/L.Salvianolic acid A (25mg/kg, ip) rat tolerance secretion to pylorus ligation has very strong restraining effect, and same dosage salvianolic acid A can weaken owing to water logging or the mandatory stomach damage that stress cause.These results show that salvianolic acid A is by suppressing stomach H +-K +/ ATP enzyme and have gastric acid inhibitory secretion and antiulcer activity.
6, the magnesium salts that alleviates uremic symptom salvianolic acid B can reduce owing to taking VITAMIN B4 and cause the concentration of urinary nitrogen in the uremic mouse blood, creatinine, methyl amidine guanidine, guanidinosuccinic acid, thereby significantly alleviates mouse retention toxication shape.
7, suppress adenylate cyclase rosmarinic acid and alkannic acid and methyl esters thereof and all have stronger restraining effect to the basic adenylate cyclase of mouse brain with 5umol/L forskolin activatory adenylate cyclase.
8, other are the anti-ageing main active ingredient of genseng as ginsenoside and some compound of phenolic acid; Tea-polyphenol is the general name of multiple phenol derivatives, accounts for 25%, and it comprises catechin, cyanidin(e), flavones and flavonol, phenolic acid four compounds.They contain poly-hydroxy, have the character of phenol, and significant pharmacological action is arranged, if can be hypoglycemic, blood fat, prevent atherosclerosis; Can with the protein bound of pathogeny bacterium such as bacterium such as intestinal bacteria in the human body, suis and typhoid fever, cholera, make it precipitation, suppress the growth of bacterium, impel the various bacteria loss of activity; Can also make harmful heavy metals such as toxic substance such as Nicotine in the human body, APOMORPHINE, quinine and lead, cobalt, silver, copper produce precipitation, weaken or eliminate hazardness.
By literature search etc., up to the present, still find no the report that reactive site or the activeconstituents of single Siberian Cocklour Fruit are followed the trail of screening, also do not see relevant report about the purposes aspect of Siberian Cocklour Fruit reactive site extract.
Summary of the invention
The technical problem that will solve required for the present invention is the new purposes that discloses the general extractive of a kind of Chinese medicine Siberian Cocklour Fruit, to overcome the above-mentioned defective that prior art exists.
That is to say, the invention is intended to the reactive site of clear and definite Chinese medicine Siberian Cocklour Fruit and activeconstituents and preparation method thereof, and then the general extractive of Siberian Cocklour Fruit is used to prepare the anti-inflammatory response product; Promptly the present invention relates to Chinese medicine Fructus Xanthii total glucosides extract and preparation method thereof, and this total glycosides extractive and the application in preparation anti-inflammatory response product such as composition such as pharmaceutical composition thereof.
Described anti-inflammatory response product is meant the product that is used for anti-inflammatory and associated conditions, the product of antiviral and associated conditions, the product of analgesia and associated conditions, diagnosis, detect, the product of treatment or research acute and chronic rhinitis and associated conditions, or diagnosis, detect, the product of treatment or research sinusitis paranasal sinusitis and associated conditions; Wherein, described anti-inflammatory response product is to comprise in anti-inflammatory response medicine, anti-inflammatory response reagent, anti-inflammatory response food or the anti-inflammatory response beverage etc. one or more, preferably anti-inflammatory reaction medicine.
(1) technical conceive
The independent development original new drug is a present urgent task of China.China's traditional Chinese medicine and pharmacy has a long history, and has also accumulated rich experience with herbal medicine prevention and treatment disease aspect, and therefore seeking effective activeconstituents from Chinese medicine is a valid approach, also is the place of the advantage of Chinese original new drug development.
The contriver has retrieved " newly organized national Chinese patent medicine ", " books such as clinical prescription handbook commonly used, " China's Chinese patent medicine complete works commonly used ", and department of eye patient's hospital administration and commercially available medicine carried out the investigation statistics analysis, discovery is in 30 kinds of conventional Chinese medicine prescriptions of treatment rhinitis, sinusitis paranasal sinusitis, have 23 kinds that contain Siberian Cocklour Fruit, account for 76.7%, and all use, be nose section key medicine as monarch drug in a prescription or ministerial drug.Therefore infer the material or the material group that in Siberian Cocklour Fruit, very likely have anti-inflammatory, antibiotic, antiviral activity.But because to its chemical constitution study not deeply, the pharmacological screening deficiency causes reactive site and activeconstituents indeterminate and do not have feasible quality standard, has limited the further development and utilization of Siberian Cocklour Fruit.
Therefore, the present invention carries out the chemical constitution study of system by the general extractive to single Siberian Cocklour Fruit medicinal material, and screens and prove the activity and the purposes of this general extractive.
Through chemical constitution study, prove that the main component in the Siberian Cocklour Fruit reactive site is diterpene glycosides compound and phenolic acid compound.And according to literature search, the contriver finds that phenolic acid compound has the number of significant pharmacologically active mostly, as famous salvianolic acid, ginkgolic acid or the like (the scape technology of passing away part), thereby the contriver infers relieving inflammation and relaxing pain, the antiviral activity of Siberian Cocklour Fruit and treats the clinical drug effect of multiple rhinopathy, should mainly be to bring into play by the drug effect of the total glycosides of reactive site Siberian Cocklour Fruit, result of study also proves and has confirmed that Fructus Xanthii total glucosides extract has significant pharmacologically active.
(2) Fructus Xanthii total glucosides extract
1, the composition of Fructus Xanthii total glucosides extract
The contriver finds mainly to contain a large amount of volatile oil, sesquiterpene lactones and water-soluble glycosides compound in the Siberian Cocklour Fruit by the Siberian Cocklour Fruit medicinal material being carried out the experimental studies such as chemical ingredients separation, purifying and structure evaluation of system.
Composition in the Fructus Xanthii total glucosides extract mainly comprises two compounds such as diterpene glycosides compound and phenolic acid compound; Above-described two compounds are the main effective constituent in the Fructus Xanthii total glucosides extract, also comprise other compositions.
Wherein, the content range of diterpene glycosides compound in this total glycosides extractive is 0.5%～99% (W/W, i.e. weight percent), preferred 5.0%～95.0%;
Wherein, the content range of phenolic acid compound in this total glycosides extractive is 0.5%～99% (W/W), preferred 5.0%～95.0%.
Wherein, the content range of other compositions in this total glycosides extractive is below 0.5%, and other compositions are to comprise in tannin, monose or polysaccharide, xanthene ketone (xanthones) or the carotenoid etc. one or more.
Existing studies show that, other compositions do not have negative influence at least to the aspects such as use of drug effect or medicine, and it is higher to separate these composition costs, therefore the necessity that is not further purified at present.
2, the chemical structure of general formula of the diterpene glycosides compound in the Siberian Cocklour Fruit is as follows:
Wherein, R 1A kind of in hydrogen, methyl or the carboxyl; R 2, R 3A kind of in hydrogen, sulfonic group, ethanoyl, propionyl or the dimethyl propylene acyl group.
Table 1 has been listed in the structural formula of part diterpene glycosides compound and R 1, R 2, R 3The corresponding relation of group:
Work as R 1=COOH, R 2=R 3During=H, expression diterpene glycosides compound A;
Work as R 1=COOH, R 2=H, R 3=COCH 2CH (CH 3) 2The time, expression diterpene glycosides compound B;
Work as R 1=COOH, R 2=SO 3 -, R 3=COCH 2CH (CH 3) 2The time, expression diterpene glycosides compound C;
Work as R 1=H, R 2=H, R 3=COCH 2CH (CH 3) 2The time, expression diterpene glycosides compound D;
Work as R 1=H, R 2=SO 3 -, R 3=COCH 2CH (CH 3) 2The time, expression diterpene glycosides compound E.
R 1 R 2 R 3
A COOH H H
B COOH H -COCH 2CH(CH 3) 2
C COOH SO 3 - -COCH 2CH(CH 3) 2
D H H -COCH 2CH(CH 3) 2
E H SO 3 - -COCH 2CH(CH 3) 2
3, the chemical structure of general formula of the phenolic acid compound in the Siberian Cocklour Fruit is as follows:
Several diterpene glycosides compound chemical structural formulas in table 1, the Siberian Cocklour Fruit
Wherein, R 1A kind of in hydrogen or the alkali metal; R 2, R 3And R 4A kind of in hydrogen or the coffee acyl.Coffee acyl is Caffeoy1, and structure is as follows:
Figure S07107686720070207D000112
Table 2 has been listed in the structural formula of part phenolic acid compound and R 1, R 2, R 3The corresponding relation of group.
Work as R 1=H, R 2=R 3=R 4During=Caffeoy1, expression phenolic acid compound A;
Work as R 1=R 3=H, R 2=R 4During=Caffeoy1, expression phenolic acid compound B;
Work as R 1=R 2=H, R 3=R 4During=Caffeoy1, expression phenolic acid compound C;
Work as R 1=K, R 2=R 4=H, R 3During=Caffeoy1, expression phenolic acid compound D.
The chemical structural formula of several phenolic acid compounds in table 2, the Siberian Cocklour Fruit
R 1 R 2 R 3 R 4
A H Caffeoy1 Caffeoyl Caffeoyl
B H Caffeoyl H Caffeoyl
C H H Caffeoyl Caffeoyl
D K H Caffeoyl H
(3) preparation method of Fructus Xanthii total glucosides extract
The preparation method of the said Fructus Xanthii total glucosides extract of the present invention comprises the steps:
(1) extract: it is some to get the Siberian Cocklour Fruit raw material, extracts, and gets extracting solution, i.e. Siberian Cocklour Fruit general extractive;
(2) separation and purification:, promptly get Fructus Xanthii total glucosides extract with the extracting solution separation and purification.
Described extracting method comprises all operable methods well known in the art such as solvent-extraction process.
The extracting method of solvent-extraction process mentioned above is the conventional extracting method of this area, that is to say to comprise ultrasonic extraction commonly used, dipping extraction method, diacolation extraction method, decoct in extraction method, heating and refluxing extraction method or the continuous backflow extraction method etc. one or more; Extraction time can be once or repeatedly.Simultaneously, factors such as the degree of grinding of raw material, extraction time, extraction temperature, appointed condition also can both influence extraction efficiency, must take in.Various extracting method comprise all technical information of ins and outs, all can be referring to relevant teaching material and relevant technical literature etc.
The routine that the employed extraction solvent of solvent-extraction process mentioned above is this area is extracted solvent, that is to say one or more of extraction such as three classes that comprise common water reagent, hydrophilic organic solvent or lipophilic organic solvent solvent;
Described water reagent is to comprise a kind of in water, sour water or the buck etc.;
Described hydrophilic organic solvent is general said and the miscible organic solvent of water, comprise in ethanol, aqueous ethanolic solution or the methyl alcohol etc. one or more, in the preferred alcohol or the Different concentrations of alcohol aqueous solution etc. one or more, the further preferred Different concentrations of alcohol aqueous solution;
Described lipophilic organic solvent is the organic solvent that generally said and water can not be miscible, comprise in sherwood oil, chloroform, ether, ethyl acetate, methylene dichloride or the ethylene dichloride etc. one or more, in preferred sherwood oil, chloroform, ether, ethyl acetate, methylene dichloride or the ethylene dichloride etc. one or more, one or more in further preferred chloroform, ether, ethyl acetate or the methylene dichloride etc.
The resulting Siberian Cocklour Fruit general extractive of said extracted method needs further separation and purification.
Described separation purification method is all operable methods well known in the art, comprise solvent separation, solvent extration (comprise in extraction process, counter current continuous extraction method, counter-current distribution method or the drop counter-current distribution method etc. one or more), the macroporous adsorbent resin method, the precipitator method, salting-out process, one or more in column chromatography or crystallization and recrystallization and the Steppecd crystallization etc.; These methods all are known technologies of this area, at needs further in the conclusive evidence, are easy to find all technical information that comprise ins and outs from relevant teaching material and relevant technical literature etc.
In order to make product property stable, easy to use and preserve, and the bioavailability that improves product, also can increase the step of an optimization, i.e. step 3:
(3) drying.
Described drying means is an operable method well known in the art, comprises that atmosphere pressure desiccation is as in oven for drying, hypobaric drying method, boulton process, spray-drying process, freeze-drying, far infrared heating drying method or micro-wave drying method etc. one or more.
In the specific implementation, need adopt wherein suitable method, and choose required measure such as appropriate condition to reach the set goal according to existing fund, technology and relevant requirement.And these methods also all are known technologies of this area, at needs further in the conclusive evidence, all are to be easy to find all technical information that comprise ins and outs from relevant teaching material and relevant technical literature etc.
(4) purposes of Fructus Xanthii total glucosides extract
1, general introduction
Further purpose of the present invention provides the new purposes in preparation anti-inflammatory response product of Fructus Xanthii total glucosides extract, and product is to comprise in medicine, reagent, the Foods or drinks etc. one or more, preferred agents.
By pharmacologically active screening proof, adopt Fructus Xanthii total glucosides extract that n-butanol extraction position or macroporous adsorbent resin 5～75% ethanol elution positions obtain for its anti-inflammatory, analgesia, antiviral or diagnosis, detect, the reactive site of treatment and research rhinopathy and associated conditions.Completed acute toxicity test proves, the mouse stomach administration surpasses 2.0g/kg to the maximum tolerated dose of this reactive site, be equivalent to 440 times of clinical recommended drug dosage, show that this efficient part is safe and reliable, solved complicated component in the Chinese medicine compound prescription, active constituent content is low and has contained the problem of toxic ingredient.
The contriver finds that Fructus Xanthii total glucosides extract has anti-inflammatory action and analgesic activity, can significantly reduce inflammation swelling degree, suppress capillary permeability, and have antivirus action.
Simultaneously, the contriver finds that Fructus Xanthii total glucosides extract can alleviate the rheum cellular infiltration due to rhinitis, the sinusitis paranasal sinusitis, eliminate the nasal mucosa oedema, thereby connective tissue proliferation can improve nasal mucosa swelling and ventilatory function under the inhibition mucous membrane, reduce nose and secrete thing, thereby inflammation is disappeared, and effect is better than clinical medicine BIYUANSHU KOUFUYE commonly used etc.
2, the using method of Fructus Xanthii total glucosides extract and composition thereof and requirement
Fructus Xanthii total glucosides extract of the present invention can be united use separately or with other active ingredient, comprises being used to prepare the product that is used to diagnose, detect, treat or study relative disease, comprises medicine, reagent, Foods or drinks etc., especially medicine.
Aspect concrete use, Fructus Xanthii total glucosides extract of the present invention can use separately, can also use with other many chemical substances.These chemical substances biologically active or have the function of treatment disease whether no matter, comprise subsidiary function as collaborative amplification, antagonism or alleviate the side effect etc. of Fructus Xanthii total glucosides extract, these chemical substances are to comprise in pharmaceutically acceptable carrier, food, natural product, chemical synthetic drug or the human medication etc. one or more; Preferably include in pharmaceutically acceptable carrier or the food etc. one or more; Further preferred pharmaceutically acceptable carrier.
" pharmaceutically acceptable carrier " used herein comprises one or more in any He all physiology suitable solvent, dispersion medium, afterbirth, antiseptic-germicide and anti-mycotic agent, isotonic agent or the absorption delay agent etc.The example of pharmaceutically acceptable carrier comprises one or more in one or more water, salt solution, phosphate-buffered saline, glucose, glycerine or ethanol or the like and the composition thereof.In many cases, in said composition, preferably include isotonic agent, for example, sugar, such as in the polyvalent alcohol of N.F,USP MANNITOL, sorbyl alcohol, sorbyl alcohol or the sodium-chlor etc. one or more.Pharmaceutically acceptable carrier can also comprise a spot of auxiliary substance, one or more in wetting agent or emulsifying agent, sanitas or the damping fluid etc. for example, and they have strengthened the validity period or the effectiveness of this Fructus Xanthii total glucosides extract.
From concrete classification, said pharmaceutically acceptable carrier is meant the pharmaceutical carrier of medicine and pharmacology field routine, comprises vehicle, as in starch or the water etc. one or more; Lubricant is as in glycerine or the Magnesium Stearate etc. one or more; Disintegrating agent is as Microcrystalline Cellulose etc.; Weighting agent is as in starch or the lactose etc. one or more; Caking agent is as in pregelatinized Starch, dextrin, derivatived cellulose, alginate, gelatin or the polyvinylpyrrolidone etc. one or more; Osmotic pressure regulator is as in glucose, sucrose, sorbyl alcohol or the N.F,USP MANNITOL etc. one or more; Thinner is as water etc.; Disintegrating agent is as in agar, lime carbonate or the sodium bicarbonate etc. one or more; Absorption enhancer is as quaternary ammonium compound etc.; Tensio-active agent is as cetyl alcohol etc.; Absorption carrier is as in kaolin or the soap clay etc. one or more; Lubricant is as in talcum powder, calcium stearate, Magnesium Stearate or the polyoxyethylene glycol etc. one or more; In addition, can also in composition, add other assistant agent, as in flavouring agent or the sweeting agent etc. one or more.
For example, the active ingredient Fructus Xanthii total glucosides extract is dissolved, suspendible or (for example be emulsifiable in the suitable aqueous solvent, distilled water, in physiological saline or the Green's solution etc. one or more) or in the oil-based solvent (for example, vegetables oil is sweet oil for example, sesame oil, Oleum Gossypii semen, in Semen Maydis oil or the propylene glycol etc. one or more) in, can make injection formulations, wherein (for example can contain dispersion agent in the solvent, Polysorbate 80, polyoxyethylene hardened castor oil 60, polyoxyethylene glycol, phenylcarbinol, in chlorobutanol or the phenol etc. one or more), osmotic pressure regulator (for example, sodium-chlor, glycerine, the D9-seminose, in D-sorbyl alcohol or the glucose etc. one or more).In this case, if necessary, can add additive, for example solubilizing agent (for example, one or more in sodium salicylate or the sodium-acetate etc.), stablizer (for example, human serum albumin etc.), pain killer (for example, phenylcarbinol etc.) etc.
Of the present invention and Fructus Xanthii total glucosides extract can also unite use with the form of composition, particularly with other chemical substance such as medicine animal especially Mammals is comprised that people or other animals treat compositions for use or similar compositions.Described Mammals comprises in people, mouse, rat, sheep, monkey, ox, pig, horse, rabbit, dog, chimpanzee, baboon, marmoset, macaque or the rhesus monkey etc. one or more.For example, Fructus Xanthii total glucosides extract of the present invention can be added be suitable for to curee's medicinal compositions in.Usually, this medicinal compositions comprises Fructus Xanthii total glucosides extract of the present invention and pharmaceutically acceptable carrier.
The composition of Fructus Xanthii total glucosides extract particularly pharmaceutical composition can have various forms, comprises in the dosage forms such as liquid, semisolid and solid for example one or more; Wherein said pharmaceutical composition comprises that the Fructus Xanthii total glucosides extract for the treatment of significant quantity is an activeconstituents, and one or more pharmaceutically acceptable carriers.
The pharmaceutical composition of Fructus Xanthii total glucosides extract can adopt conventional production method well known in the art to make various formulations, and activeconstituents is mixed with one or more carriers, is made into required formulation then.Described formulation comprises one or more in tablet, capsule, granule, suspensoid, emulsion, solution, syrup or the injection etc., takes one or more route of administration in oral or injection (comprise in intravenous injection, intravenous drip, intramuscular injection or the subcutaneous injection etc. one or more), the mucous membrane dialysis etc. to carry out diagnosis, detection, treatment or the scientific research of anti-inflammatory, antiviral, analgesia and acute and chronic rhinitis, sinusitis paranasal sinusitis and associated conditions.
It is 0.5%～99% activeconstituents Fructus Xanthii total glucosides extract that pharmaceutical composition preferably contains weight ratio, further preferably contain weight ratio and be 1%～95% activeconstituents Fructus Xanthii total glucosides extract, most preferably contain weight ratio and be 5%～90% activeconstituents Fructus Xanthii total glucosides extract.
The pharmaceutical composition of Fructus Xanthii total glucosides extract generally must be aseptic and stable under the production condition of storage.Can be with this group. compound is mixed with solution, microemulsion, dispersion liquid, liposome or other is suitable for the ordered structure of high drug level.By with a kind of of this Fructus Xanthii total glucosides extract of aequum and required mentioned component or combine to add in the appropriate solvent and then carry out Sterile Filtration and prepare aseptic parenteral solution.Generally speaking, prepare dispersion liquid by this Fructus Xanthii total glucosides extract being added in the aseptic solvent that contains basic dispersion medium and required above-mentioned other composition.Under the situation of the sterile powder that is used to prepare aseptic parenteral solution, the preparation method of recommendation is vacuum-drying and lyophilized preparation.For example, by passing through to keep required granular size such as the dressing of Yelkin TTS, under the situation of dispersion liquid and, can keeping the adequate liquidity of solution by using tensio-active agent.By comprising that in said composition the medicament (for example Monostearate or gelatin) that postpones to absorb can reach the prolongation absorption of injectable composition.
When being used for the patient, Fructus Xanthii total glucosides extract dosage of the present invention is 5～20mg/kgd, and this dosage or consumption decide according to patient or user's the age and the situation of body weight and physical appearance or patient's symptom usually.
Fructus Xanthii total glucosides extract of the present invention and medicinal compositions thereof can comprise the Fructus Xanthii total glucosides extract of the present invention of " treatment significant quantity " or " prevention significant quantity "." treatment significant quantity " is meant at the dosage of necessity and effectively reaches the amount of required result of treatment under the time.The treatment significant quantity of Fructus Xanthii total glucosides extract can cause that at this individuality the factors such as ability of required reaction change according to the patient's condition, age, sex and body weight and this Fructus Xanthii total glucosides extract such as individuality.The treatment significant quantity also refers to that the useful result of treatment of this Fructus Xanthii total glucosides extract surpasses the amount of its any toxicity or harmful effect." prevention significant quantity " is meant the amount that effectively reaches required preventive effect under necessary dosage and time.Because preventive dose is used for the ill preceding or early stage curee of disease, the prevention significant quantity is usually less than the treatment significant quantity.The typical non-limiting scope of the treatment of Fructus Xanthii total glucosides extract of the present invention or prevention significant quantity is 5～20mg/kg, more preferably 5～10mg/kg.Should note, dose value will change according to disease type of desiring to alleviate and seriousness, that is to say when being used for the patient that the dosage of Fructus Xanthii total glucosides extract of the present invention or consumption decide according to patient or user's the age and the situation of body weight and physical appearance or patient's symptom usually.In addition; should understand; for any specific curee; should along with the time according to individual need and give with or supervision give with the people's of described composition professional judgement and adjust the given dose system; and the dosage range that this paper sets only be illustrative, the scope or the practice of the composition of can't requirement for restriction protecting.
That is to say, need be according to object, route of administration, institute's disease of treat and the situation etc. of treatment, variation Fructus Xanthii total glucosides extract of the present invention at every turn and/or dosage or the consumption of every day.For example, give Mammals through vein, grownup (as body weight 60kg) especially, the single dose of described Fructus Xanthii total glucosides extract is about 5～10mg, preferably about 10mg, preferred administration every day 1～3 time.Can adjust dose unit, to propose the best required reaction of arch (for example treatment or prevention are replied).For example, can single heavy dose of administration can give several divided doses or reduce or increase dosage in proportion according to the urgency of treatment situation in for some time.It is especially favourable that preparation is easy to the non-enteron aisle composition of the unified dosage unit form of administration and dosage.Dosage unit form used herein refers to be suitable for the physical sepn unit of dosage unit of the mammalian subject of desire treatment; The calculating that each unit contains predetermined amount is used for together producing with required pharmaceutical carrier the actives Fructus Xanthii total glucosides extract of required result of treatment.The specification of dosage unit form of the present invention, determine and directly depend on the specific characteristic of following (a) this Fructus Xanthii total glucosides extract and the particular treatment of desiring to reach or preventive effect and (b) interior in mixing this technology that is used for the treatment of the individual sensitivity Fructus Xanthii total glucosides extract by following in restriction.
3, the pharmaceutical dosage form of Fructus Xanthii total glucosides extract and composition thereof and route of administration
Fructus Xanthii total glucosides extract of the present invention and preparation of compositions anti-inflammatory response product thereof, wherein according to the product of the requirement of beverage, food technology field preparation can anti-inflammatory, antiviral, analgesia and diagnose, detect, treat or study acute and chronic rhinitis, sinusitis paranasal sinusitis and associated conditions thereof; Can be used in patient's treatment or health care according to the product of the requirement of medical technical field preparation, can either be directly used in the medicine of preparation treatment or health care separately, also can mix with many chemical substances or make up, directly or indirectly be used to prepare the medicine of treatment or health care.Chemical substance described here is above described identical with this section.
In the present invention, required material comprises raw material of the present invention, above-mentioned matching used chemical substance etc., all should adopt the material of food grade or pharmaceutical grade according to practical situation and needs.
Fructus Xanthii total glucosides extract of the present invention and composition thereof can be with the whole bag of tricks administration known in the art, although route of administration/administering mode of recommending in many therepic use is sprays or oral administration.But the technician will appreciate that route of administration/administering mode changes with required result.In some concrete enforcement, the carrier that this active compound can avoid snap-out release with this compound of protection is preparation example such as empty release formulation together, comprises that graft transfer system, transdermal paste one or more in transfer system or the micro-capsule transfer system etc.In addition, can also use biodegradable, biocompatible polymer, for example one or more in ethylene-ethyl acetate, polyanhydride, polyglycolic acid, collagen protein, polyorthoesters or the poly(lactic acid) etc.Prepare the equal patent applied for of many methods of this preparation or generally known to those skilled in the art (referring to for example Sustained and Controlled Release Drug Delivery Systems, J.R.Robinson edits, Marcel Dekker, Inc., New York, 1978).
Fructus Xanthii total glucosides extract of the present invention and composition thereof, usually by oral, snuffing is gone into, one or more modes in rectum or the administered parenterally etc., is applied to the patient who needs this treatment.
Be used for when oral, can be made into conventional solid preparation such as in tablet, pulvis, granula or the capsule etc. one or more.When implementing, Fructus Xanthii total glucosides extract of the present invention can be together oral with for example inert diluent or assimilable edible carrier.This Fructus Xanthii total glucosides extract (with its composition altogether, if desired) can also be wrapped in hard or soft shell gelatin capsules, is pressed into tablet or directly adds in curee's the meals.About oral therapeutic administration, described Fructus Xanthii total glucosides extract can be added with vehicle and use with one or more forms in edible tablet, buccal tablet agent, tincture, capsule, suspension, syrup or wafer or the like.
For to give Fructus Xanthii total glucosides extract of the present invention outside the parenterai administration, may need with preventing that the material of its inactivation from together giving to this Fructus Xanthii total glucosides extract dressing or with this Fructus Xanthii total glucosides extract.The active compound that replenishes can also be added in the said composition.In the specific implementation, Fructus Xanthii total glucosides extract of the present invention and one or more other medicines that can be used for the treatment of disease are prepared altogether and/or given altogether.Thisly unite use, can utilize this medicine that gives primely, therefore avoid possible toxicity or the complication relevant with various monotherapies than low dosage.
Make in liquid preparation such as aqua, oil-suspending agent or other liquid preparation one or more, as in syrup or the elixir etc. one or more; When being used for administered parenterally, can be made in solution, aqua or the oiliness suspension agent etc. of injection one or more.
In the above-described type of service, preferred form is one or more in tablet, coated tablet, capsule, suppository, nasal spray, nasal drop or the injection etc., in further preferred nasal spray, nasal drop or the tablet etc. one or more, preferred especially nasal spray.
In addition, the employed medicinal raw material of Fructus Xanthii total glucosides extract also can be directly used in preparation anti-inflammatory response product in some cases separately, also can mix with many chemical substances or make up, directly or indirectly be used to prepare the anti-inflammatory response product with the form of composition.Chemical substance described here is above described identical with this section.
For example, the powder of the employed medicinal raw material of Fructus Xanthii total glucosides extract is used to prepare the particularly various formulations of medicine of anti-inflammatory response product, or the powder of the employed medicinal raw material of Fructus Xanthii total glucosides extract is used to prepare the especially various formulations of medicine of anti-inflammatory response product with relevant auxiliary material, or the powder of the employed medicinal raw material of Fructus Xanthii total glucosides extract and relevant preparation anti-inflammatory response product such as medicine one are used from the various formulations of preparation anti-inflammatory response product such as medicine, or the powder of the employed medicinal raw material of Fructus Xanthii total glucosides extract and relevant ancillary drug one are used from the various formulations of preparation anti-inflammatory response product such as medicine, as tablet, capsule, in granule or the suspensoid etc. one or more, preferred capsule.
One of described method is that the powder can with the employed medicinal raw material of Fructus Xanthii total glucosides extract is a capsule, two of method is to be capsule with the powder of the employed medicinal raw material of Fructus Xanthii total glucosides extract and relevant preparation anti-inflammatory response product such as medicine can together, and three of method is to be capsule with the powder of the employed medicinal raw material of Fructus Xanthii total glucosides extract with relevant ancillary drug can together; Four of method is the powder of the employed medicinal raw material of Fructus Xanthii total glucosides extract directly to be pressed together according to a conventional method with relevant auxiliary material be tablet or granule, five of method is the powder of the employed medicinal raw material of Fructus Xanthii total glucosides extract, relevant preparation anti-inflammatory response product such as medicine directly to be pressed according to a conventional method with relevant auxiliary material together be that tablet or granule, six of method are the powder of the employed medicinal raw material of Fructus Xanthii total glucosides extract, relevant ancillary drug directly to be pressed according to a conventional method with relevant auxiliary material together be tablet or granule etc.
Except that six kinds of above-mentioned basic skills, can also select other forms of the employed medicinal raw material of Fructus Xanthii total glucosides extract or the employed medicinal raw material of Fructus Xanthii total glucosides extract is carried out after method well known in the art handles, prepare the product that contains the employed medicinal raw material of Fructus Xanthii total glucosides extract such as the medicine of various formulations.But, it should be noted that, in the employed medicinal raw material of above-mentioned direct use Fructus Xanthii total glucosides extract, should be earlier according to the dosage requirement of employed Fructus Xanthii total glucosides extract, conversion obtains the consumption of the employed medicinal raw material of Fructus Xanthii total glucosides extract of required use.
In sum, Fructus Xanthii total glucosides extract of the present invention and composition thereof can be used for preparing the anti-inflammatory response product, preferred agents and food, further preferred agents.
(5) technology speciality
The present invention studies Fructus Xanthii total glucosides extract targetedly, and this raw material is safe in utilization, takes into account each other, one-object-many-purposes has been brought into play effect to greatest extent, and use range is wide especially, therefore apply easily, can have a tremendous social and economic benefits in the short period of time.
That is to say, result of study of the present invention can further deeply be developed as have a potential applicability in clinical practice prevent and treat especially new drug of rhinitis, sinusitis paranasal sinusitis, relieving inflammation and relaxing pain and anti-virus product.This product has the advantage that determined curative effect, effective dose are low, have no side effect, and domestic with China, international like product is compared has significant advantage.Acute and chronic sinusitis paranasal sinusitis is common clinical, frequently-occurring disease, the deterioration of the serious day by day and environment that pollutes along with global atmosphere, and the sickness rate of respiratory system diseases such as expectation sinusitis paranasal sinusitis will constantly rise.Therefore, the present invention also can be follow-up new drug research and lays a good foundation, and further produces bigger economic benefit and social benefit.
Through secular pharmacology test, Fructus Xanthii total glucosides extract have anti-inflammatory, antiviral, ease pain and treat activity acute and chronic rhinitis, sinusitis paranasal sinusitis and associated conditions thereof, directly use Fructus Xanthii total glucosides extract, need not be through the metabolism of gi tract bacterium, make effect more direct, avoid that gastrointestinal bacterial flora between the individuality is active variantly to be caused the difference of meta-bolites and produce difference on the drug effect, thereby overcome the unmanageable problem of Chinese medicine dosage, and improved bioavailability.
Fructus Xanthii total glucosides extract pharmacological action of the present invention is stronger, and its raw material sources are abundant, and preparation technology is simple, the yield height.
Fructus Xanthii total glucosides extract also is the activity form in the gi tract bio-transformation, directly uses Fructus Xanthii total glucosides extract, and the bioavailability of medicament height can accurately be controlled dosage.The Fructus Xanthii total glucosides extract stable in properties uses the quality of the pharmaceutical preparations of Fructus Xanthii total glucosides extract preparation stable.
In addition, the Fructus Xanthii total glucosides extract chemical property is stable, anti-inflammatory, antiviral, ease pain and to treat effect acute and chronic rhinitis, sinusitis paranasal sinusitis and associated conditions thereof obvious, so its be more suitable for anti-inflammatory, antiviral, ease pain and treat suitability for industrialized production acute and chronic rhinitis, sinusitis paranasal sinusitis and associated conditions medicine thereof.
In a word, active adaption of the present invention the need of work of modern medical service, food, beverage and scientific research field and the needs of human nature service, be the safe raw material that is used to prepare the anti-inflammatory response product, directly or indirectly anti-inflammatory, antiviral, the analgesia and diagnose, detect, treat or study acute and chronic rhinitis, sinusitis paranasal sinusitis and associated conditions thereof.
Embodiment
The present invention has studied the purposes of Fructus Xanthii total glucosides extract, a kind of particularly raw material of medicine of preparation anti-inflammatory response product such as medicine etc. or anti-inflammatory response product that can be used in is provided, be convenient to the safe handling in medical industry and fields such as relevant industries such as food, beverage, comprise diagnosis, detection, treatment or the scientific research etc. of disease.
Be example with the solvent-extraction process below, elaborate the concrete operation method of preparation Fructus Xanthii total glucosides extract.
(1) extraction: it is some to get the Siberian Cocklour Fruit medicinal material, adds the extraction solvent and mixes, and extracts, and with extracting liquid filtering, concentrated, promptly gets Siberian Cocklour Fruit medicinal material general extractive.
(2) separation and purification: Siberian Cocklour Fruit medicinal material general extractive through purification procedures, is obtained Fructus Xanthii total glucosides extract.
Here said extraction, separation purification method comprise solvent-extraction process as indicated above, solvent extration or extraction well known in the art, separation purification method such as macroporous adsorbent resin method, column chromatography.Specifically:
In step 1:
1. in the solvent-extraction process that is adopted, extracting solvent is to comprise water, in alcohols or other organic solvents etc. one or more, described alcohols extracts solvent and comprises methyl alcohol, ethanol, aqueous ethanolic solution, in propyl alcohol or the butanols etc. one or more, described other organic solvents comprise ethyl acetate, acetone etc., preferably water, methyl alcohol, ethanol, aqueous ethanolic solution, propyl alcohol, butanols, ethyl acetate, in acetone and other organic solvent or its mixed solvent one or more, further preferably include a kind of in ethanol or the aqueous ethanolic solution etc., preferred especially 60%～90% aqueous ethanolic solution.
2. in the solvent-extraction process that is adopted, one or more in the preferred ultrasonic extraction of extracting method, diacolation extraction method or the heating and refluxing extraction method etc., further preferred heating and refluxing extraction method; Extraction time can be one or many.
3. with the extracting solution filtration under diminished pressure, concentrate Siberian Cocklour Fruit medicinal material general extractive, the yield of Siberian Cocklour Fruit medicinal material general extractive is 5.0%～20%, promptly Siberian Cocklour Fruit medicinal material general extractive accounts for 5.0%～20% of Siberian Cocklour Fruit medicinal material gross weight.
In step 2:
1. the separation purification method preferred solvent extraction process that is adopted is about to the water-dispersion of Siberian Cocklour Fruit medicinal material general extractive, behind petroleum ether degreasing, adopts suitable organic solvent extraction with the weeding of grease soluble components again, obtains extraction leftover; Or directly extract with the weeding of grease soluble components with suitable organic solvent, obtain extraction leftover; Described suitable organic solvent can select for use in chloroform, methylene dichloride, ether or the ethyl acetate etc. one or more to extract; Extraction times can be one or many.
2. in the solvent extration that is adopted, also need extraction leftover, continue to adopt n-butanol extraction gained behind the extraction fat-soluble component, divide and get n-butanol layer, after adding anhydrous sodium sulfate dehydration, the concentrating under reduced pressure n-butanol portion promptly gets Fructus Xanthii total glucosides extract.At this moment, the yield of Fructus Xanthii total glucosides extract is 1%～10%, and promptly Fructus Xanthii total glucosides extract accounts for 1%～10% of Siberian Cocklour Fruit medicinal material gross weight.
3. the separation purification method that is adopted also can adopt the macroporous adsorbent resin method.The macroporous adsorbent resin method that is adopted, can be with Siberian Cocklour Fruit medicinal material total glycosides extractive reclaim under reduced pressure to there not being the alcohol flavor, filter to get filtrate, filtrate is transferred to relative density 1.0～1.1 with distilled water, last macroporous adsorptive resins, wash the solubility impurity that anhydrates with water, continue and carry out wash-out, collect 5～75% ethanol elution positions, promptly get the elutriant that is rich in phenolic acids and diterpene glycosides compound with the eluting solvent such as the Different concentrations of alcohol aqueous solution, reclaim under reduced pressure promptly gets Fructus Xanthii total glucosides extract to doing.At this moment, the yield of Fructus Xanthii total glucosides extract is 0.5%～10%, and promptly Fructus Xanthii total glucosides extract accounts for 0.5%～10% of Siberian Cocklour Fruit medicinal material gross weight.Preferred eluting solvent is that concentration is 40% aqueous ethanolic solution.
4. the macroporous adsorbent resin preparation method thereof of Fructus Xanthii total glucosides extract, can adopt the macroporous adsorbent resin of multiple model, comprise in the nonpolar and low-pole resin such as D101, D520, D4006, H103, AB-8, Dianion HP 20 or XAD-7 one or more, also can be other can replace above-mentioned resin on performance filler, among preferred AB-8, D101 or the D520 etc. one or more, preferred especially AB-8.
Generally speaking, in the preparation method of Fructus Xanthii total glucosides extract, be to be raw material based on fresh medicinal material of Siberian Cocklour Fruit or commercially available medicinal material; After the raw material pulverizing, adopt in solvent-extraction process, solvent extration or the macroporous adsorbent resin method etc. one or more in turn, promptly get the crude product of Fructus Xanthii total glucosides extract; If in conjunction with in the conventional drying method such as concentrating under reduced pressure drying, spraying drying, lyophilize one or more, then can prepare the medicinal extract or the dry thing of Fructus Xanthii total glucosides extract crude product.
If further adopt column chromatography etc. to separate purification process, then can access phenolic acid compound in the Fructus Xanthii total glucosides extract and diterpene glycosides compound etc.; At this moment, phenolic acid compound that obtains and diterpene glycosides compound account for the content of Fructus Xanthii total glucosides extract 50%～100%, wherein, the diterpene glycosides compound accounts for 0.5%～99% (W/W) of Fructus Xanthii total glucosides extract content, and phenolic acid accounts for 0.5%～99% (W/W) of total glycosides extractive content.
Be example with several representative dosage forms below, elaborate the concrete preparation method of the various formulations of Fructus Xanthii total glucosides extract.
The present invention prepares powder injection and generally adopts conventional freeze-drying, as solvent, the steps include: to get Fructus Xanthii total glucosides extract with water, adds vehicle, is dissolved in water, and adds gac, filtration sterilization, and plug is partly rolled in can, and lyophilize, tamponade are rolled lid and are got final product.Used vehicle is selected from one or more in N.F,USP MANNITOL, gelatin hydrolysate, glucose, lactose or the dextran etc.Every bottle contains Fructus Xanthii total glucosides extract 10～100mg.
The present invention prepares powder injection also can adopt spray-drying process, as solvent, the steps include: to get Fructus Xanthii total glucosides extract with water, adds or do not add vehicle (vehicle is the same), be dissolved in water, add gac, filtration sterilization, spraying drying, aseptic subpackaged, tamponade is rolled lid and is got final product.Every bottle contains Fructus Xanthii total glucosides extract 10～100mg.
When the present invention prepared small-volume injection, preparation got final product as solvent with water for injection, also can add appropriate amount of auxiliary materials, and auxiliary material is selected from one or more in ethanol, propylene glycol, glycerine, polyoxyethylene glycol, peruscabin or the N,N-DIMETHYLACETAMIDE etc.Every contains Fructus Xanthii total glucosides extract 10～100mg.
The present invention prepares glucose infusion liquid or sodium-chlor transfusion, with water for injection as solvent, add the preparation of an amount of glucose or sodium-chlor and get final product, also can add appropriate amount of auxiliary materials, auxiliary material is selected from one or more in ethanol, propylene glycol, glycerine, polyoxyethylene glycol, peruscabin or the N,N-DIMETHYLACETAMIDE etc.Every bottle contains Fructus Xanthii total glucosides extract 10～100mg.
The present invention prepares oral preparations such as tablet, capsule, granule, oral liquid, and auxiliary material can be lactose, starch, dextrin, stearate etc., technology preparation routinely.
In the present invention, the example of above-described embodiment and the following stated all is in order to set forth the present invention better, is not to be used for limiting scope of invention.
Below by embodiment the present invention is described in detail.
The preparation method 1 of embodiment 1, Fructus Xanthii total glucosides extract
The dry medicinal material 2.5Kg of Siberian Cocklour Fruit, with 50 liters of refluxing extraction of 90% ethanolic soln 2 times, each 2 hours, merge extracted twice liquid, concentrating under reduced pressure obtains medicinal extract 350g, after the dispersion of 2 premium on currency, divide three extraction degreasings with 6 liters of sherwood oils in turn, respectively with 6 liters of chloroforms, 6 liters of each three abstraction impurity removal matter of ethyl acetate; Extraction leftover divides three extractions with 6 liters of propyl carbinols, combining extraction liquid, and lyophilize gets Fructus Xanthii total glucosides extract 21g.
The preparation method 2 of embodiment 2, Fructus Xanthii total glucosides extract
The dry medicinal material 2.5Kg of Siberian Cocklour Fruit, with 50 liters of supersound extraction of 70% ethanolic soln 2 times, each 2 hours, merge extracted twice liquid, concentrating under reduced pressure obtains medicinal extract 208g, after the dispersion of 2 premium on currency, divide three extraction degreasings with 6 liters of sherwood oils in turn, respectively with 6 liters of chloroforms, 6 liters of each three abstraction impurity removal matter of ethyl acetate; Extraction leftover divides three extractions with 6 liters of propyl carbinols, combining extraction liquid, and reclaim under reduced pressure gets Fructus Xanthii total glucosides extract 17g to doing.
The preparation method 3 of embodiment 3, Fructus Xanthii total glucosides extract
The dry medicinal material 2.5Kg of Siberian Cocklour Fruit, extract 2 times with 50 liters of diacolations of 75% ethanolic soln, each 24 hours, merge extracted twice liquid, concentrating under reduced pressure obtains medicinal extract 285g, after the dispersion of 2 premium on currency, divide three extraction degreasings with 6 liters of sherwood oils in turn, respectively with 6 liters of chloroforms, 6 liters of each three abstraction impurity removal matter of ethyl acetate; Extraction leftover divides three extractions with 6 liters of propyl carbinols, combining extraction liquid, and reclaim under reduced pressure gets Fructus Xanthii total glucosides extract 19g to doing.
The preparation method 4 of embodiment 4, Fructus Xanthii total glucosides extract
The dry medicinal material 2.5Kg of Siberian Cocklour Fruit, with 50 liters of refluxing extraction of 75% ethanolic soln 2 times, each 2 hours, merge extracted twice liquid, reclaim under reduced pressure filters to get filtrate to there not being the alcohol flavor, filtrate transfers to relative density 1.05 with distilled water, last D101 macroporous adsorptive resins washes the solubility impurity that anhydrates with water, continues and uses the different concentration ethanol wash-out, collect 50% ethanol elution position, promptly get the elutriant that is rich in phenolic acid glycoside and diterpene glycosides compound, reclaim under reduced pressure gets Fructus Xanthii total glucosides extract 15g to doing.
The preparation method 5 of embodiment 5, Fructus Xanthii total glucosides extract
The dry medicinal material 2.5Kg of Siberian Cocklour Fruit, with 50 liters of refluxing extraction of 75% ethanolic soln 2 times, each 2 hours, merge extracted twice liquid, reclaim under reduced pressure filters to get filtrate to there not being the alcohol flavor, filtrate transfers to relative density 1.05 with distilled water, last AB-8 macroporous adsorptive resins washes the solubility impurity that anhydrates with water, continues and uses the different concentration ethanol wash-out, collect 50% ethanol elution position, promptly get the elutriant that is rich in phenolic acid glycoside and diterpene glycosides compound, reclaim under reduced pressure gets Fructus Xanthii total glucosides extract 20g to doing.
The preparation of embodiment 6, Fructus Xanthii total glucosides extract nasal drops
Get the above-mentioned Fructus Xanthii total glucosides extract 45g that obtains, add Fel Sus domestica unguentum 20g, chlorpheniramine maleate 0.5g, Sodium Houttuyfonate 8g, add 10 times of distilled water dilutings, elimination is not tolerant, bottling, and sterilization is sealed and is promptly got the Fructus Xanthii total glucosides extract nasal drops.
Embodiment 7, Fructus Xanthii total glucosides extract drip capsular preparation
Get the above-mentioned Fructus Xanthii total glucosides extract 40g that obtains, add Fel Sus domestica unguentum 15, chlorpheniramine maleate 0.3g, Sodium Houttuyfonate 6g, adding weighting agent, 0.5～10% disintegrating agent carboxymethyl base sodium cellulosate, hydroxypropylcelluloses such as 40%～60% starch, dextrin, carboxymethyl starch, secondary calcium phosphate makes particle and makes it dry, and add glidant Magnesium Stearate, differential silica gel, make it dry, in incapsulating then, obtain product, i.e. the Fructus Xanthii total glucosides extract capsule.
The preparation of embodiment 8, Fructus Xanthii total glucosides extract capsule
(1) prescription
Fructus Xanthii total glucosides extract 1000.0g
Microcrystalline Cellulose 1000g
Sodium starch glycolate 140g
Dehydrated alcohol is an amount of
Talcum powder 80g
Make 10000 capsules altogether
(2) preparation technology gets in bulk drug Fructus Xanthii total glucosides extract and the prescription other auxiliary material respectively by above prescription and crosses 100 mesh sieves respectively, put 60 ℃ of oven dry, take by weighing recipe quantity Fructus Xanthii total glucosides extract and Microcrystalline Cellulose, the sodium starch glycolate equivalent method of progressively increasing mixes, with an amount of dehydrated alcohol system softwood, 30 mesh sieves are granulated, 50～60 ℃ of dryings 2 hours, with the whole grain of 30 mesh sieves, the talcum powder and the sodium starch glycolate that add recipe quantity mix.
The preparation of embodiment 9, Fructus Xanthii total glucosides extract powder injection
Get Fructus Xanthii total glucosides extract 30g, add dextran 30g, add 500ml water for injection, stir and make its dissolving; Add the injection water to 2000ml, add the 3.0g needle-use activated carbon, fully stirred 30 minutes; Decarbonization filtering; With 0.22 μ m filtering with microporous membrane; Be filled in the aseptic cillin bottle, every bottle of 2ml partly rolls plug; Lyophilize, tamponade is rolled lid and is got final product again.
The preparation of embodiment 10, Fructus Xanthii total glucosides extract powder injection
Get Fructus Xanthii total glucosides extract 60g, add 500ml water for injection, stir and make its dissolving; Add the injection water to 1000ml, add the 1g needle-use activated carbon, fully stirred 30 minutes; Decarbonization filtering; With 0.221 μ m filtering with microporous membrane; Lyophilize gets sterilized powder, is distributed into 1000 bottles.
The preparation of embodiment 11, Fructus Xanthii total glucosides extract powder injection
Get Fructus Xanthii total glucosides extract 40g, add lactose 50g, add 100ml water for injection, stir and make its dissolving; Add the injection water to 1000ml, add the 1.5g needle-use activated carbon, fully stirred 30 minutes; Decarbonization filtering; Use the 0.22gm filtering with microporous membrane; Spraying drying gets sterilized powder, is distributed into 1000 bottles.
The preparation of embodiment 12, Fructus Xanthii total glucosides extract powder injection
(1) prescription
Injection Fructus Xanthii total glucosides extract work in-process 150g
N.F,USP MANNITOL 400g
Water for injection adds to 10000ml
Make 10000 bottles altogether
(2) preparation technology
Take by weighing the recipe quantity Fructus Xanthii total glucosides extract by above prescription, join in an amount of water for injection, stir and make its dissolving; Add recipe quantity N.F,USP MANNITOL, stir and make dissolving fully, add to the full amount of water for injection; Add 0.1% needle-use activated carbon of amount of liquid, fully stirred 30 minutes; Decarbonization filtering; With 0.22 μ m filtering with microporous membrane; Plug is partly rolled in can; Lyophilize, lid is rolled in tamponade.Make 9735 bottles altogether, yield rate is 97.35%.
The preparation of embodiment 13, Fructus Xanthii total glucosides extract small-volume injection
Get Fructus Xanthii total glucosides extract 5g, add 100ml water for injection, stir and make its dissolving; Add the injection water to 1000ml, with 0.22 μ m filtering with microporous membrane; The packing embedding, every bottle of 10ml, sterilization gets final product.
The preparation of embodiment 14, Fructus Xanthii total glucosides extract small-volume injection
Get Fructus Xanthii total glucosides extract 10g, add propylene glycol 30g, add 200ml water for injection, stir and make its dissolving; Add the injection water to 1000ml, add the 1.5g needle-use activated carbon, fully stirred 30 minutes: decarbonization filtering; Use the 0.22gm filtering with microporous membrane; The packing embedding, every bottle of 5ml, sterilization gets final product.
The preparation of embodiment 15, Fructus Xanthii total glucosides extract glucose infusion liquid
Get Fructus Xanthii total glucosides extract 2g, add polyoxyethylene glycol 10g, add glucose 500g, add 2000ml water for injection, stir and make its dissolving; Add the injection water to 5000ml: with 0.22 μ m filtering with microporous membrane; The packing embedding, every bottle of 100ml, sterilization gets final product.
The preparation of embodiment 16, Fructus Xanthii total glucosides extract glucose infusion liquid
Get Fructus Xanthii total glucosides extract 2g, add glucose 250g, add 1000ml water for injection, stir and make its dissolving; Add the injection water to 5000ml; With 0.22 μ m filtering with microporous membrane; The packing embedding, every bottle of 250ml, sterilization gets final product.
The preparation of embodiment 17, the transfusion of Fructus Xanthii total glucosides extract sodium-chlor
Get Fructus Xanthii total glucosides extract 1g, add sodium-chlor 90g, add 1000ml water for injection, stir and make its dissolving; Add the injection water to 10000ml; With 0.22 μ m filtering with microporous membrane; The packing embedding, every bottle of 250ml, sterilization gets final product.
The preparation of embodiment 18, Fructus Xanthii total glucosides extract tablet
Get Fructus Xanthii total glucosides extract 80g, Microcrystalline Cellulose 80g, lactose 15g, pregelatinized Starch 60g sieve, and mix, and with an amount of 10%PVP ethanolic soln system softwood, granulate, and drying adds Magnesium Stearate 3g, whole grain, and compressing tablet is made 1000.
The preparation of embodiment 19, Fructus Xanthii total glucosides extract tablet
(1) prescription
Fructus Xanthii total glucosides extract 1000.0g
Microcrystalline Cellulose 1170.0g
Pregelatinized Starch 690.0g
Lactose 125.0g
The 5%PVP dehydrated alcohol is an amount of
Magnesium Stearate 15.0g
Make 10000 altogether
(2) preparation technology
Take by weighing the main ingredient and the auxiliary material of recipe quantity respectively by above prescription, mix the back according to making softwood, system particle under the formulation and technology item by the equivalent method of progressively increasing, dry, processes such as whole grain, the heavy back of sheet Singlepunchtabletpress and 10.5mm shallow concave punch compressing tablet have been calculated, control nude film hardness 5-7kg makes 9698 in tablet altogether, and yield rate is 96.98%.
Adopt lift-over spray method dressing, art for coating is as follows:
The preparation of coating liquid: the molten film dress material of stomach: 85G61235 is provided by Shanghai Colorcon Coating Technology Co., Ltd
Art for coating: will treat that (hardness 5kg～7kg) puts into coating pan to the dressing nude film, start whipping appts and air blast heating unit, when treating that the nude film temperature rises to 40 ℃, last 1/3 place that begins to open spray gun alignment tab bed sprays into the coating liquid dressing, 38 ℃～42 ℃ of control strip bed tempertaures, gas pound pressure 6kg, the coating liquid flow velocity is 50mL/min, coating membrance heavily account for coating tablet heavy 3%.
The analgesic activity of embodiment 20, Fructus Xanthii total glucosides extract
Getting the above-mentioned Fructus Xanthii total glucosides extract that obtains (is called for short: CE) in right amount, adopt acetic acid induced mice writhing response model, observe the analgesic activity of the total glycosides of Siberian Cocklour Fruit.
(1) experimental technique
Get 60 of 20 ± 2g mouse, male and female half and half, random packet.Each group press dosage successive administration 3d in the table 6 respectively, and before the last administration 30min abdominal injection 0.7% glacial acetic acid solution (0.1ml/10g mouse), the interior mouse writhing number of times of observed and recorded 10min the results are shown in Table 3 behind the 5min.
(2) experimental result
Table 3 is the result show, each group of CE can significantly reduce acetic acid induced mice writhing response number of times, has analgesic activity.
The influence of table 3, CE Dichlorodiphenyl Acetate induced mice writhing response (X ± SD, n=10)
Figure S07107686720070207D000251
Compare with the physiological saline group, *P＜0.05, *P＜0.01
Embodiment 21, Fructus Xanthii total glucosides extract are to the therapeutic action of experimental sinusitis paranasal sinusitis
(be called for short: CE) in right amount, adopt rabbit experiment sinusitis paranasal sinusitis model, the total glycosides of om observation Siberian Cocklour Fruit is to the influence of rabbit nasal mucosa techtology to get the above-mentioned Fructus Xanthii total glucosides extract that obtains.
(1) experimental technique
Choose about body weight 2.5kg 56 of healthy new zealand white rabbits, male and female half and half, random packet.First day, left side maxillary sinus Dou Kou was opened in general anesthesia, blocks one-sided Dou Kou, operation stitching with gelfoam.Whole process is undertaken by aseptic technique.Inject 108 CFU/ml streptococcus pneumoniae suspension 0.5ml next day, the administration group is tied medicine 10d continuously by dosage in the table 1, after the last administration separation and Culture cell, draw materials, make section.Light microscopic is observed down following index: 1. nasal mucosa thickness, for ease of the location relatively, with ocular micrometer record every part of sample mucosal protrusion summit to the thickness (comprising epithelial lining and tunica propria) of nasal septal cartilage place lateral margin as mucosal thickness; 2. body of gland number in the proper mucous membrane is as the criterion with the mean number of body of gland number under the bilateral mucosal protrusion; 3. mucous epithelium goblet cell number is as the criterion with the mean number of counting 5 high power field goblet cell sums at random; 4. lymphatic nodule number in the proper mucous membrane is the sum of lymphatic nodule in the section.
(2) experimental result
Observation analysis is respectively organized the nasal mucosa techtology and is changed, and the results are shown in Table 4.
Table 3, table 4 presentation of results, the middle and high dosage group of CE significantly alleviates the rheum cellular infiltration, eliminate the nasal mucosa oedema, suppress connective tissue proliferation under the mucous membrane, alleviate the effect of glandular hyperplasia in nasal mucosa epithelial goblet cell and the proper mucous membrane, the every index of techtology totally is better than the levofloxacin group, and high dose group is better than the BIYUANSHU group.
Table 4, CE to the influence of rabbit nasal sinus mucosal tissue morphological indexes (X ± SD, n=8)
Compare with model group, *P＜0.05, *P＜0.01
Embodiment 22, Fructus Xanthii total glucosides extract influenza virus restraining effect
(1) experimental technique
1. MDCK (Madin darby canin kidney) passage and influenza virus (first 1 influenza virus) are cultivated: press document (Guo Yuanji, Cheng Xiaowen; 1997) method is carried out.
2. cell toxicity test: sample is added 0.1mL/ hole in the cell plate that grown up to monolayer cell, and add cell maintenance medium, cultivate 72h, the observation of cell pathology in 37 ℃, 5%CO2 incubator to the 1mL/ hole.Establish the mdck cell contrast simultaneously.Experiment repeats 2 times.The result shows: sample does not produce non-specific cell pathology (CPE) to mdck cell.
3. sample resisiting influenza virus test: 96 hole mdck cell culture plate culturing cells, establish cell control group, virus control group, positive controls and test group respectively.First 1 influenza virus is added virus control group and test group, 37 ℃ of absorption 2h, sucking-off virus.The different concns sample is joined each test group respectively, and 37 ℃, 5%CO2 were cultivated 3 days, viewing test result, and calculate the 50% inhibition concentration (IC of different pharmaceutical to virus 50).
(2) experimental result (seeing: table 5)
Experimental result shows that Fructus Xanthii total glucosides extract has the obvious suppression effect to influenza virus.
Table 5, Fructus Xanthii total glucosides extract are to the restraining effect of influenza virus
Group IC 50(mmol/L)
CE 4.2
Ribavirin 3.9

Claims (19)

1. the application of the composition of Fructus Xanthii total glucosides extract in preparation anti-inflammatory response product, described anti-inflammatory response product is meant the product that is used for anti-inflammatory and associated conditions, the product of antiviral and associated conditions, the analgesia and the product of associated conditions, or diagnosis, detect, in the product of treatment or research sinusitis paranasal sinusitis and associated conditions one or more;
The preparation method of described Fructus Xanthii total glucosides extract comprises the steps:
(1) extract: it is some to get the Siberian Cocklour Fruit raw material, extracts, and gets extracting solution, i.e. Siberian Cocklour Fruit general extractive;
(2) separation and purification:, promptly get Fructus Xanthii total glucosides extract with the extracting solution separation and purification.
Described separation purification method is one or more in solvent extration or the macroporous adsorbent resin method;
The operation steps of described solvent extration is:
(1) with the water-dispersion of Siberian Cocklour Fruit medicinal material general extractive, behind petroleum ether degreasing, adopt suitable organic solvent extraction again with the weeding of grease soluble components, obtain extraction leftover; Extraction times can be an one or many.
(2) extraction leftover is continued to adopt propyl carbinol extract, divide and get n-butanol layer, behind the adding anhydrous sodium sulfate dehydration, the concentrating under reduced pressure n-butanol portion promptly gets Fructus Xanthii total glucosides extract.
2. the application of the composition of Fructus Xanthii total glucosides extract according to claim 1 is characterized in that, described anti-inflammatory response product is to comprise in medicine, reagent, the Foods or drinks one or more.
3. the application of the composition of Fructus Xanthii total glucosides extract according to claim 2 is characterized in that, described anti-inflammatory response product is the medicine of diagnosis, detection, treatment or research sinusitis paranasal sinusitis and associated conditions.
4. the application of the composition of Fructus Xanthii total glucosides extract according to claim 1 is characterized in that, described this total glycosides extractive is the general extractive that comprises diterpene glycosides compound, phenolic acid compound and other compositions.
5. the application of the composition of Fructus Xanthii total glucosides extract according to claim 4, it is characterized in that described diterpene glycosides compound, phenolic acid compound and the content range of other compositions in this total glycosides extractive be respectively 0.5%～99% (weight percent), below 0.5%～99% and 0.5%.
6. the application of the composition of Fructus Xanthii total glucosides extract according to claim 5 is characterized in that, described diterpene glycosides compound and the content range of phenolic acid compound in this total glycosides extractive are respectively 5%～95% and 5%～95%.
7. the application of the composition of Fructus Xanthii total glucosides extract according to claim 4 is characterized in that, the chemical structure of general formula of diterpene glycosides compound is as follows:
Figure FSB00000019904700011
Wherein, R 1A kind of in hydrogen, methyl or the carboxyl; R 2, R 3A kind of in hydrogen, sulfonic group, ethanoyl, propionyl or the dimethyl propylene acyl group.
8. the application of the composition of Fructus Xanthii total glucosides extract according to claim 7 is characterized in that, described diterpene glycosides compound is to comprise in the following compound one or more:
Work as R 1=COOH, R 2=R 3During=H, expression diterpene glycosides compound A;
Work as R 1=COOH, R 2=H, R 3=COCH 2CH (CH 3) 2The time, expression diterpene glycosides compound B;
Work as R 1=COOH, R 2=SO 3 -, R 3=COCH 2CH (CH 3) 2The time, expression diterpene glycosides compound C;
Work as R 1=H, R 2=H, R 3=COCH 2CH (CH 3) 2The time, expression diterpene glycosides compound D;
Work as R 1=H, R 2=SO 3 -, R 3=COCH 2CH (CH 3) 2The time, expression diterpene glycosides compound E.
9. the application of the composition of Fructus Xanthii total glucosides extract according to claim 4 is characterized in that, the chemical structure of general formula of described phenolic acid compound is as follows:
Figure FSB00000019904700021
Wherein, R 1A kind of in hydrogen or the alkali metal; R 2, R 3And R 4A kind of in hydrogen or the coffee acyl.
10. the application of the composition of Fructus Xanthii total glucosides extract according to claim 9 is characterized in that, described phenolic acid compound is to comprise in the following compound one or more:
Work as R 1=H, R 2=R 3=R 4During=coffee acyl, expression phenolic acid compound A;
Work as R 1=R 3=H, R 2=R 4During=coffee acyl, expression phenolic acid compound B;
Work as R 1=R 2=H, R 3=R 4During=coffee acyl, expression phenolic acid compound C;
Work as R 1=K, R 2=R 4=H, R 3During=coffee acyl, expression phenolic acid compound D.
11. the application of the composition of Fructus Xanthii total glucosides extract according to claim 1 is characterized in that, described suitable organic solvent is to comprise in chloroform, methylene dichloride, ether or the ethyl acetate one or more.
12. the application of the composition of Fructus Xanthii total glucosides extract according to claim 1 is characterized in that, the operation of described macroporous adsorbent resin method comprises the steps:
(1) Siberian Cocklour Fruit medicinal material total glycosides extractive reclaim under reduced pressure is not distinguished the flavor of to there being alcohol, filter to get filtrate;
(2) filtrate is transferred to relative density 1.0～1.1 with distilled water, last macroporous adsorptive resins washes the solubility impurity that anhydrates with water;
(3) carry out wash-out with eluting solvent, collect 5～75% ethanol elution positions, promptly get the elutriant that is rich in phenolic acids and diterpene glycosides compound;
(4) reclaim under reduced pressure promptly gets Fructus Xanthii total glucosides extract to doing.
13. the application of the composition of Fructus Xanthii total glucosides extract according to claim 12 is characterized in that, described eluting solvent is the Different concentrations of alcohol aqueous solution.
14. the application of the composition of Fructus Xanthii total glucosides extract according to claim 13 is characterized in that, described eluting solvent is that concentration is 40% aqueous ethanolic solution.
15. the application of the composition of Fructus Xanthii total glucosides extract according to claim 12 is characterized in that, described macroporous adsorbent resin is the macroporous adsorbent resin that comprises multiple model.
16. the application of the composition of Fructus Xanthii total glucosides extract according to claim 15 is characterized in that, described macroporous adsorbent resin is to comprise that non-polar resin, low-pole resin or other can replace a kind of in the filler of above-mentioned resin on performance.
17. the application of the composition of Fructus Xanthii total glucosides extract according to claim 16, it is characterized in that described non-polar resin and low-pole resin are to comprise a kind of among D101, D520, D4006, H103, AB-8, Dianion HP 20 or the XAD-7.
18. the application of the composition of Fructus Xanthii total glucosides extract according to claim 1 is characterized in that, the preparation method of described Fructus Xanthii total glucosides extract also comprises the exsiccant step.
19. the application of the composition of Fructus Xanthii total glucosides extract according to claim 18, it is characterized in that described drying means is to comprise in atmosphere pressure desiccation, hypobaric drying method, boulton process, spray-drying process, freeze-drying, far infrared heating drying method or the micro-wave drying method one or more.
CN2007100076867A 2005-03-28 2005-03-28 Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction Expired - Fee Related CN1994352B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100076867A CN1994352B (en) 2005-03-28 2005-03-28 Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100076867A CN1994352B (en) 2005-03-28 2005-03-28 Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100246939A Division CN100464760C (en) 2005-03-28 2005-03-28 Application of Xanthium glycosides extract in the preparation of anti-inflammatory reaction products

Publications (2)

Publication Number Publication Date
CN1994352A CN1994352A (en) 2007-07-11
CN1994352B true CN1994352B (en) 2010-11-10

Family

ID=38249608

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100076867A Expired - Fee Related CN1994352B (en) 2005-03-28 2005-03-28 Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction

Country Status (1)

Country Link
CN (1) CN1994352B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108514568A (en) * 2018-05-14 2018-09-11 黑龙江中医药大学 The preparation method and its medical usage of thiazides compounds in the achene of Siberian cocklebur
CN109528796A (en) * 2018-12-11 2019-03-29 江西赣隆药业有限公司 A kind of Siberian cocklebur grass granule and preparation method thereof
CN110038023B (en) * 2019-04-19 2021-05-07 温州医科大学 A pharmaceutical composition for replacing the antiallergic activity of Xanthium
CN110585384A (en) * 2019-10-11 2019-12-20 文莉 Pharmaceutical composition for removing dampness and diminishing inflammation and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1460492A (en) * 2003-06-03 2003-12-10 广西亿康药业股份有限公司 Chinese medicine preparation for curing acute and chronic rhinitis and its production method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1460492A (en) * 2003-06-03 2003-12-10 广西亿康药业股份有限公司 Chinese medicine preparation for curing acute and chronic rhinitis and its production method

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
张巧艳.苍耳及其同属药用植物研究进展.解放军药学学报19 2.2003,19(2),122-125.
秦路平
郑汉臣
陈瑶
韩婷
韩婷;秦路平;郑汉臣;陈瑶;张巧艳.苍耳及其同属药用植物研究进展.解放军药学学报19 2.2003,19(2),122-125. *

Also Published As

Publication number Publication date
CN1994352A (en) 2007-07-11

Similar Documents

Publication Publication Date Title
WO2018058261A1 (en) Traditional chinese medicine composition for treating psoriasis and preparation method thereof
CN104013668B (en) Licoflavone class extract is used to prepare to be applied in treatment ulcerative colitis medicine
CN104116734B (en) A kind of pharmaceutical composition, pharmaceutical preparation and application and method for making for the treatment of oral cavity, pharyngolaryngitis
CN114699467B (en) Traditional Chinese medicine for clearing lung and reducing fever and application thereof
CN105920476A (en) Traditional Chinese medicine composition for prophylaxis and treatment of Alzheimer disease and preparation method thereof
KR102567235B1 (en) Composition for the prevention and treatment of Inflammatory Bowl Disease
CN101637492A (en) Preparation method of total flavonoids in persimmon leaves and application of total flavonoids in liver-protecting drugs and health foods
CN1883484B (en) Novel pharmacological use of cucurbitacine
WO2015192758A1 (en) Anti-tumor pharmaceutical application of pentacyclic triterpene saponin compounds of szechuan melandium root
CN113773409B (en) Polysaccharides from Scutellaria saponifera and its application
CN104857154A (en) Traditional Chinese medicine composition for treating three-high diseases and preparation method therefor
CN103989763B (en) A kind ofly be used for the treatment of compound arthritis capsule of hemophiliac joints pathological changes and preparation method thereof
CN101181285A (en) Application of astragaloside IV in the preparation of drugs for treating neurodegenerative diseases
CN103182064A (en) Medicine for treating cough due to wind-cold evil and preparation method thereof
CN1994352B (en) Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction
CN101439069B (en) Leaf extract of scutellaria chinensis, its preparation method and its application
WO2009062374A1 (en) The pharmaceutical use of liquiritigenin for preparing medicine for treating neurodegenerative diseases
WO2006063515A1 (en) Use of radix sanguisorbae and its extract for preparing medicament to increase rbc and hemoglobin
CN105213615A (en) Compound Solanum Nigrum Pianomide
CN100482266C (en) Medical composite prepared by sarcandra and oldenlandia
CN1947747B (en) Traditional Chinese medicine composition containing luteolin and capsule of sweeping forsythia and its preparation method and use
CN103933386B (en) Compound hemophiliac capsule used for treating hemophilia and preparation method thereof
CN109197917A (en) The Chinese medicine compound prescription conditioning liquid and its preparation method and application for preventing and treating hand-foot-and-mouth disease
CN112089783A (en) Application of traditional Chinese medicine composition in preparation of medicine for preventing or/and treating obesity
CN101450093A (en) Use of epomedium total-flavone in preparing target organ protection medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101110

Termination date: 20140328